Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease - PubMed (original) (raw)

Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease

Zhou-wen Chen et al. J Zhejiang Univ Sci B. 2008 Aug.

Abstract

Objective: To investigate the relationship between alanine aminotransferase (ALT) levels and metabolic syndrome (MS) in nonalcoholic fatty liver disease (NAFLD).

Methods: A total of 26527 subjects who received medical health checkup in our hospital from January 2005 to July 2007 were enrolled in the study. The diagnosis of fatty liver was based on ultrasound imaging. MS was defined according to the criteria of the Adult Treatment Panel III. ALT, triglyceride (TG), high density lipoprotein cholesterol (HDL-c), fasting plasma glucose (FPG), height, weight, waist circumference (WC), systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured in each subject to analyze the relationship between MS and ALT activity.

Results: (1) The prevalence of NAFLD in men (30.94%) was significantly higher than that in women (15.65%); (2) The incidence of MS in NAFLD (33.83%) was significantly greater than that in non-NAFLD (10.62%); (3) Of the 6470 subjects with NAFLD, in the age-adjusted partial correlation analysis, there were statistically significant correlations between the ALT levels and most metabolic risk factors in each sex (P<0.01), except that ALT levels had no correlation with HDL-c in women. Moreover, in the multiple stepwise regression analysis, SBP lost its significance, and WC, body mass index (BMI), age, DBP, TG and FPG were independently associated with ALT levels in both sexes (P<0.05). HDL-c remained significant and was independently related to ALT levels in men; (4) ALT levels were significantly higher in subjects with MS compared to those without MS (P<0.001). Mean ALT levels increased with the number of MS components in each sex (P<0.05 for trend).

Conclusion: We found a strong relationship between ALT levels and MS in NAFLD and revealed that the cluster of MS components might be the predictor for ALT elevations.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Mean ALT levels stratified by age group and sex

Fig. 2

Fig. 2

Mean ALT levels according to the number of metabolic syndrome (MS) components by sex

References

    1. Adams LA, Angulo P, Keith D. Nonalcoholic fatty liver disease. CMAJ. 2005;172(7):899–905. doi: 10.1503/cmaj.045232. - DOI - PMC - PubMed
    1. Arun J, Clements RH, Lazenby AJ, Leeth RR, Abrams GA. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obes Surg. 2006;16(10):1351–1358. doi: 10.1381/096089206778663715. - DOI - PubMed
    1. Brunt EM. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Semin Diagn Pathol. 2005;22(4):330–338. doi: 10.1053/j.semdp.2006.04.002. - DOI - PubMed
    1. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005;42(5):987–1000. doi: 10.1002/hep.20920. - DOI - PubMed
    1. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol. 2007;22(6):778–787. doi: 10.1111/j.1440-1746.2007.05001.x. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources